TRIB1 and cancer: TRIB1 and HDACs play crucial roles in cisplatin-induced enrichment of cancer stem cells (CSCs) and drug resistance in NSCLC, and patients with high levels of TRIB1 had a significantly poorer response to cisplatin and a poorer prognosis [39].